tiprankstipranks
Osmotica Pharmaceuticals Plc (OSMT)
NASDAQ:OSMT
US Market
Holding OSMT?
Track your performance easily

Osmotica Pharmaceuticals (OSMT) Stock News & Sentiment

0 Followers
Gauging Osmotica Pharma’s Risk Factors Post Q2
Premium
Market News
Gauging Osmotica Pharma’s Risk Factors Post Q2
3y ago
Osmotica Pharmaceuticals (OSMT) is an integrated specialty pharmaceutical company. Its Upneeq is the only FDA-approved ophthalmic solution for treating acquired blepharoptosis in adults. Osmotica expects to complete the sale of ...Read more
Osmotica Tanks 25% As FDA Requests Efficacy Study For Arbaclofen
Premium
Market News
Osmotica Tanks 25% As FDA Requests Efficacy Study For Arbaclofen
4y ago
3 Biotech Stocks Under $4 That Could Surge Over 50%
Premium
Ideas & Insights
3 Biotech Stocks Under $4 That Could Surge Over 50%
5y ago

News Score - Last 7 Days

Neutral
OSMT
Sector Average
Media Buzz
This Week6 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OSMT’s Media Buzz Sentiment?
6 articles about OSMT were published this week. In an average week, 3 articles are published.
    What is OSMT’s weekly average amount of articles?
    In an average week, 3 articles about OSMT are published.
      What is OSMT’s News Sentiment?
      100% of articles about OSMT were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        CLNNClene
        BAXBaxter International
        GMDAGamida Cell
        NSCIFNanalysis Scientific
        UNHUnitedHealth
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis